Physician profile
Thad R Jackson
NPI 1134177108
$835.12
in general payments reported to CMS, 2019-2025
20 companies · $65.88 in 2025
The $65.88 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $113 · 2021: $237 · 2022: $171 · 2023: $84.69 · 2024: $21.63 · 2025: $65.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $172.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $130.20 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $115.59 | 2019-2022 | |
| Abbvie INC. | $103.92 | 2021-2025 | |
| Amgen INC. | $76.34 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $68.62 | 2022-2025 | Soliris, Ultomiris |
| Sk Life Science, INC. | $44.78 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $32.01 | 2023 | Austedo Xr |
| Astrazeneca Pharmaceuticals LP | $30.11 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $28.26 | 2021 | |
| Argenx US, INC. | $21.68 | 2023 | Vyvgart |
| Ucb, INC. | $21.63 | 2024 | Rystiggo |
| Biohaven Pharmaceuticals, INC. | $21.20 | 2021 | |
| Zogenix INC. | $20.84 | 2021 | |
| Si-Bone, INC. | $19.88 | 2019 | |
| Lilly USA, LLC | $19.71 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $18.65 | 2019 | |
| Collegium Pharmaceutical, INC. | $17.99 | 2022 | |
| Stryker Corporation | $17.27 | 2025 | N/A |
| Banner Life Sciences, LLC | $14.37 | 2022 | |
| Neurelis, INC. | $12.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thad Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.